|
Delayed
NSE India S.E.
00:19:13 2026-11-18 EST
|
5-day change | 1st Jan Change | ||
| 2,039.20 INR | +1.51% |
|
+0.06% | +40.77% |
| Market Cap | 326B 3.49B 3.17B 2.93B 2.64B 4.99B 5.18B 35.3B 13.96B 176B 13.11B 12.83B 557B | P/E 2025 |
-472x | P/E 2026 | 89.7x |
|---|---|---|---|---|---|
| Enterprise Value | 342B 3.66B 3.32B 3.07B 2.77B 5.23B 5.43B 36.98B 14.63B 185B 13.73B 13.44B 583B | EV / Sales 2025 |
8.1x | EV / Sales 2026 | 5.97x |
| Free-Float |
48.99% | Yield 2025 * |
-
| Yield 2026 | - |
| Markets | Quality | ||
|---|---|---|---|
NSE India S.E.
| WOCKPHARMA | Delayed | |
| WOCKPHARMA | Delayed |
| 1 day | +1.34% | ||
| 1 week | +0.06% | ||
| Current month | +7.09% | ||
| 1 month | +6.79% | ||
| 3 months | +9.46% | ||
| 6 months | +29.55% | ||
| Current year | +40.77% |
| 1 week | 1,983.4 | 2,075.5 | |
| 1 month | 1,772 | 2,089 | |
| Current year | 1,086.7 | 2,422.3 | |
| 1 year | 1,086.7 | 2,422.3 | |
| 3 years | 321 | 2,422.3 | |
| 5 years | 145.15 | 2,422.3 | |
| 10 years | 145.15 | 2,422.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 2009-03-31 | |
Deepak Madnani
DFI | Director of Finance/CFO | - | 2022-02-28 |
Mahesh V. Patel
CTO | Chief Tech/Sci/R&D Officer | - | 1998-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | 2009-11-05 | |
| Director/Board Member | 53 | 2009-11-05 | |
| Director/Board Member | 55 | 1996-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.51% | +0.06% | +51.43% | +515.42% | 3.47B | ||
| -1.13% | -1.17% | +38.55% | +139.23% | 1,275B | ||
| -1.36% | -0.74% | +39.64% | +86.06% | 680B | ||
| -0.59% | -0.36% | +25.14% | +111.73% | 521B | ||
| -0.76% | +1.10% | +41.43% | +70.96% | 389B | ||
| -0.75% | -3.16% | +54.39% | +40.90% | 356B | ||
| -1.83% | -0.89% | +26.00% | +58.48% | 305B | ||
| -1.65% | -0.59% | +1.55% | +34.52% | 287B | ||
| -0.95% | -1.57% | +34.01% | +72.55% | 250B | ||
| +1.60% | -0.36% | +37.21% | +125.66% | 208B | ||
| Average | -0.61% | -0.46% | +34.93% | +125.55% | 428B | |
| Weighted average by Cap. | -0.98% | -0.55% | +34.97% | +95.96% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 30.35B 325M 295M 272M 246M 464M 482M 3.28B 1.3B 16.38B 1.22B 1.19B 51.74B | 34.62B 371M 336M 311M 280M 529M 549M 3.74B 1.48B 18.68B 1.39B 1.36B 59.02B |
| Net income | -470M -5.03M -4.57M -4.22M -3.81M -7.18M -7.46M -50.83M -20.11M -254M -18.87M -18.48M -801M | 2.13B 22.8M 20.7M 19.12M 17.25M 32.56M 33.81M 230M 91.11M 1.15B 85.53M 83.73M 3.63B |
| Net Debt | 14.33B 153M 139M 129M 116M 219M 227M 1.55B 613M 7.73B 575M 563M 24.43B | 15.53B 166M 151M 139M 126M 237M 246M 1.68B 664M 8.38B 624M 611M 26.48B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-18 | ₹2,039.20 | +1.51% | 446,999 |
| 26-11-17 | ₹2,008.90 | +0.22% | 319,693 |
| 26-11-16 | ₹2,004.50 | -1.12% | 561,715 |
| 26-11-13 | ₹2,027.20 | -1.30% | 392,517 |
| 26-11-12 | ₹2,054.00 | +0.95% | 342,889 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- WOCKPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
















